About 3.2 million people in the United States are chronically infected with HCV and each year, about 17,000 people are newly infected.

FDA Approves Rapid Test for Antibodies to Hepatitis C Virus

The agency announced approval of The OraQuick HCV Rapid Antibody Test, the first rapid blood test for antibodies to the virus for individuals 15 and older.

The Food and Drug Administration has announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals aged 15 years and older.

The OraQuick HCV Rapid Antibody Test is used to test individuals who are at risk for infection with HCV and people with signs or symptoms of hepatitis. HCV is transmitted through exposure to infected blood, which, for example, can occur during intravenous drug use. The virus can also be transferred from an infected mother to her child. Hepatitis C can lead to liver inflammation and dysfunction and, over time, to liver disease and liver cancer.

OraQuick is a test strip and does not require an instrument for diagnosis. It takes about 20 minutes to obtain results from the test.

"Approval of OraQuick means that more patients can be notified of their HCV infection faster so that they can consult with their physicians for appropriate health measures," said Jeffrey Shuren, M.D., J.D., director of FDA's Center for Devices and Radiological Health. "Getting faster treatment is an important public health step to control this dangerous disease."

OraQuick is not approved for HCV screening of the general population.

According to the Centers for Disease Control and Prevention, there are approximately 3.2 million people in the United States chronically infected with HCV and each year, about 17,000 people are newly infected. Chronic HCV infection is a leading reason for a liver transplants in the United States and HCV is associated with an estimated 12,000 deaths annually. Approximately 75 to 85 percent of people who become infected with the hepatitis C virus develop chronic infection.

OraQuick is manufactured by Bethlehem, Penn.-based OraSure Technologies Inc.

Download Center

  • Hand Safety Program

    Hand injuries are the #1 preventable industrial accident worldwide. In REThink Hand Safety, the most comprehensive book on hand safety, you'll learn how top companies have reduced hand injuries by up to 90% and what the most successful hand safety programs have in common. Get your free copy today.

  • Free 1-on-1 Consultations

    Get a free meeting with a Superior Glove hand safety expert and learn how to have less hand injuries, lower PPE costs, and increase worker productivity. 1-on-1 consultations provide you with personalized advice and recommendations for your specific needs and concerns.

  • Glove 101 Guide

    In this comprehensive guide, we've compiled all the key information you need to know about safety gloves to help you make informed decisions when choosing gloves for your workers. Whether you're new to the world of safety gloves or an experienced pro, this guide has something for everyone.

  • Sample Program

    Find the right safety gloves for your team and try before you buy—in just 3 easy steps! Simply add the products to your sample box, complete the request form, and wait for your samples to arrive at no cost to you.

  • Cut Protection Product Guide

    Find the right safety gloves for your workers to protect them from cut hazards. This guide offers a wide selection of gloves, including ultra-thin gloves with the industry’s maximum cut resistance for unbeatable dexterity and touch sensitivity.

  • Superior Glove

OH&S Digital Edition

  • OHS Magazine Digital Edition - February March 2023

    February March 2023

    Featuring:

    • IH: GAS DETECTION
      Does Real-Time Data Enhance Gas Detection Programs?
    • PPE: HEARING PROTECTION
      Hearing Protection: The Dangers of Non-Compliance
    • PPE: PROTECTIVE APPAREL
      Personal Protective Equipment: The Pains of Staying Pain-Free
    • CONSTRUCTION SAFETY
      Reframing Eyewear: Meeting Workforce Needs with Technology and Advancements
    View This Issue